U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07154134) titled 'Endocan and Copeptin Serum Levels in Preterm Neonates With Respiratory Distress Syndrome' on Aug. 27.
Brief Summary: This work aims to investigate and compare the levels of serum endocan and serum copeptin on the first day of life and correlate their levels to the severity of respiratory distress in preterm neonates suffering from respiratory distress syndrome.
Study Start Date: July 10
Study Type: OBSERVATIONAL
Condition:
Endocan
Copeptin
Serum
Preterm Neonates
Respiratory Distress Syndrome
Intervention:
DIAGNOSTIC_TEST: Serum endocan
Serum endocan will be measured by an enzyme-linked immunosorbent assay (ELISA) on the first...